OOIR: Observatory of International Research

Papers

(The median citation count of Best Practice & Research in Clinical Rheumatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
The importance of functional genomics studies in precision rheumatology	106
Novel therapies – IMID Co-morbidities	93
Update of imaging in the assessment of axial spondyloarthritis	86
CAR T-cell therapy and indications for pediatric rheumatology	83
Predicting and preventing clinical psoriatic arthritis	63
Raynaud's phenomenon and digital ulceration in systemic sclerosis	51
A review of the advances in understanding the genetic basis of spondylarthritis and emerging clinical benefit	49
Possible future avenues for myositis therapeutics: DM, IMNM and IBM	47
Chimeric antigen receptor T-cell (CAR-T) therapy and other cellular immunotherapy treatments for idiopathic inflammatory myopathies	46
Rehabilitation interventions in osteoarthritis	45
Epidemiology of rheumatic diseases in tropical populations	42
Rheumatic manifestations of HIV/AIDS	41
The inequity of global healthcare in pediatric rheumatology	37
Environmental factors and rheumatic diseases	35
Erratum to “Editorial Board” [Best Pract Res Clin Rheumatol (2025) 102094]	34
New age of Lupus Nephritis: Updates in guidelines, biomarkers, and therapies	29
Novel therapies in Sjögren’s disease: A systematic review of the literature	29
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus	29
Pathophysiology and immunolgical basis of axial spondyloarthritis	29
Novel therapies for axial spondyloarthritis and future directions	28
Oral and maxillofacial manifestations of systemic sclerosis	26
Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus	26
Index for PART A	26
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis	25
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases	25

Decoding pain in axial spondyloarthritis: Mechanisms, management, and future directions	24
Genetics of rheumatoid arthritis	24
Genetics of osteoarthritis	24
Global epidemiology of psoriatic arthritis	24
Difficult to treat disease in psoriatic arthritis- is it different from axial spondyloarthritis?	24
The challenges in managing Psoriatic Arthritis in resource poor settings	23
Editorial Board	23
Patient-reported outcomes in vasculitis	23
Osteoporosis in 2022: Care gaps to screening and personalised medicine	23
Novel therapies and innovation for systemic sclerosis skin ulceration	23
Index	22
Editorial Board	22
CAR T cell therapy: Autoimmune neurological uses and neurotoxicities	21
Preclinical RA: How to halt its progression	21
Imaging of crystal-induced arthropathies in 2025	20
The burden of osteoarthritis: Is it a rising problem?	20
Editorial Board	20
Diagnostic delay in axial spondylarthritis: A lost battle?	20
Physiotherapy and occupational therapy in rheumatoid arthritis: Bridging functional and comorbidity gaps	20
Where is bone science taking us?	20
Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?	20
The role of ultrasound and magnetic resonance imaging in the assessment of musculoskeletal involvement in systemic lupus erythematosus: A review of recent advances and insights	20
Systemic lupus erythematosus	20
Improving quality of care in systemic sclerosis	19
Bedside labial salivary gland biopsy (LSGBx: Lip biopsy): An update for rheumatologists	19
Pregnancy & neonatal outcomes in spondyloarthritis	19
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome	19
Gastrointestinal involvement in systemic sclerosis: A spotlight on small bowel involvement, complications and management	18
Calcinosis in dermatomyositis: Origins and possible therapeutic avenues	18
Novel biomarkers in RA: Implication for diagnosis, prognosis, and personalised treatment	18
New and future therapies: Changes in the therapeutic armamentarium for SLE	18
Imaging rheumatology: Emerging tools and expanding applications	17
Malignancy and rheumatic diseases	17
Novel therapies in treatments of SLE	17
Infection associated Vasculitides	17
Problems with “Problems with opioids beyond misuse”	17
CAR-T cell therapy for ANCA-associated vasculitis: Rationale, current evidence, and future directions	15
Granzyme K+ CD8 T cells in autoimmunity	14
Exercise in myositis: What is important, the prescription or the person?	14
Pregnancy in systemic lupus erythematosus	14
Editorial Board	14
Emerging insights in tropical rheumatology: Challenges, clinical manifestations, and recent advances	13
Editorial Board	13
Risk for osteoporosis and fracture with glucocorticoids	13
Index	12
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment	12
Exploring osteoarthritis: Unraveling challenges, innovations, and hope for a better future	11
Regenerative methods in osteoarthritis	11
Clinical assessment of Psoriatic Arthritis	11
When are patients with osteoarthritis referred for surgery?	11

Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions	11
What the rheumatologist needs to know about skin biopsy	11
Best practice and research advances in many aspects of rheumatology	11
Pharmacogenetics of therapies in rheumatoid arthritis: An update	11
Pain in osteoarthritis from a symptom to a disease	10
Musculoskeletal complications in sickle cell disease: Pathophysiology, diagnosis and management	10
Idiopathic inflammatory myopathies: Progress, challenges, and future perspectives	10
Impact of sex and gender on axSpA diagnosis and outcomes	10
Physical rehabilitation interventions for hand function in people with systemic sclerosis	10
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus	10
Synovial fluid analysis: Relevance for daily clinical practice	10
Treatment of rheumatic adverse events of cancer immunotherapy	10
Complexity to clarity: Advancing the science and care of systemic sclerosis	9
TNFR2 signalling in inflammatory diseases	9
Recent targets of osteoarthritis research	9
Juvenile systemic sclerosis	9
Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis	9
Practical utilization of sonography for the assessment of muscle diseases in rheumatology	9
Editorial Board	9
Muscle imaging in myositis: MRI, US, and PET	8
Femoroacetabular impingement – What the rheumatologist needs to know	8
Pain syndromes	8
Introduction to the issue: Cellular therapies in rheumatology	8
IgG4-Related disease: From diagnosis to remission	8
Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?	8
CARD9 in the pathogenesis of axial spondyloarthritis	8
Interferonopathies: From concept to clinical practice	8
Novel Therapy	8
Preface: Pediatric rheumatology	8
Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free remission	7
Novel therapies in axial spondyloarthritis	7
Exploring the role of gut microbes in spondyloarthritis: Implications for pathogenesis and therapeutic strategies	7
Novel therapies in SSc	7
Pain mechanisms for the practicing rheumatologist	7
Cutaneous manifestations in myositis syndromes	7
Insights into the genetic landscape of systemic sclerosis	7
Pipeline treatments on psoriatic disease	6
Editorial Board	6
Myofascial pain – A major player in musculoskeletal pain	6
Tropical pyomyositis	6
Imaging in sarcoid disease	6
Cardiovascular risk in vasculitis	6
Interstitial lung disease imaging for autoimmune diseases	6
Management of glucocorticoid-induced osteoporosis in rheumatic diseases	6
The global burden of fragility fractures – what are the differences, and where are the gaps	6
Advances in imaging techniques for Sjogren's disease	6
Bridging clinical phenotypes with molecular mechanisms in autoimmune irAEs: An Etiopathogenic framework	5
Cancer and myositis: Who, when, and how to screen	5
How to treat monogenic SLE?	5
Horizon scan: State-of-the-art therapeutics for psoriatic arthritis	5
Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases	5
Screening, monitoring and treatment of interstitial lung disease in systemic sclerosis	5
Cardiac sarcoidosis: An algorithmic approach to diagnosis and treatment of the “Great Mimicker”	5
Musculoskeletal manifestations in leprosy	5
New developments in ultrasound and MRI imaging of pediatric rheumatic diseases	5
Non-coding DNA variants for risk in lupus	4
Microbiota and immune dynamics in rheumatoid arthritis: Mechanisms and therapeutic potential	4
The promise of imaging in psoriatic arthritis	4
Management of pregnant with rheumatoid arthritis: Preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes	4
Cervicogenic headache – How to recognize and treat	4
To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question	4
Challenges in the diagnosis of axial spondyloarthritis	4
Treatment overview of axial spondyloarthritis in 2023	4
Genetics of vasculitis	4
Vascular ultrasound in rheumatology practice	4
Magnetic resonance imaging in spondyloarthritis: Friend or Foe?	4
Practical approaches for clinicians in chronic pain management: Strategies and solutions	4
Osteoporosis and fragility fractures – Why is there still avoidable disability and death?	4